HXGCF yields 250.00% · PFE yields 6.13%● Live data
📍 HXGCF pulled ahead of the other in Year 1
Combined, HXGCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HXGCF + PFE for your $10,000?
Hexagon Composites ASA, together with its subsidiaries, produces and sells composite pressure cylinders and fuel systems in Norway, Europe, North America, South-East Asia, the Middle East, and internationally. The company operates through Hexagon Agility & CNG LDV, Hexagon Purus, Hexagon Digital Wave, and Hexagon Ragasco LPG segments. The Hexagon Agility & CNG LDV segment provides clean fuel solutions for commercial vehicles, passenger vehicles, and gaseous energy transportation. Hexagon Purus segment provides high pressure cylinders, vehicle systems, and battery backs for fuel cell and battery electric vehicles. The Hexagon Digital Wave segment offers cylinder testing and monitoring technology solutions that reduce down-time and inspection costs while improving inspection accuracy. The Hexagon Ragasco LPG segment manufacturers composite liquefied petroleum gas (LPG) cylinders for leisure, household, and industrial applications. Hexagon Composites ASA was incorporated in 1985 and is headquartered in Ålesund, Norway.
Full HXGCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.